In vivo efficacy of a refillable intrawound drug delivery device in a sheep model of biofilm-compromised open fracture-related infection
Year: 2025
Type: article
Abstract: CFU. The hypothesis was supported. The Pouch received Breakthrough Device Designation by the FDA, is being transitioned toward clinical trials, and is a potential solution to the long-standing problem of open fracture-related infection.
Source: Biofilm
Authors: Dustin Williams, David Rothberg, Walker Kay, Lisa Nehring, Robert Falconer, Richard Tyler Epperson, Brooke Kawaguchi, Carolyn Ardizzone, Brian Barnum, Nicholas Ashton
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,140
OpenAlex ID: W4407461931
